- Guidelines for Multiple Myeloma 2012: status of lenalidomide in the treatment of refractory / relapsed disease2012 | Faculty of Medicine in Hradec Králové
- Bortezomib (velcade) for refractory/relapsed multiple myeloma-results of Czech myeloma group (CMG) and Slovak myeloma society (SMS)Publication without faculty affiliation
- Treatment of relapsed and refractory multiple myeloma2021 | Faculty of Medicine in Hradec Králové
- Low-dose thalidomid in refractory and relapsing multiple myeloma2007 | First Faculty of Medicine
- Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Aplasia After Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome2019 | First Faculty of Medicine
- Hodgkin lymphoma - hendless story Hodgkin lymphoma - endless story2019 | Third Faculty of Medicine
- Salvage Treatment and the Role of Transplantation in Lymphomas2015 | First Faculty of Medicine
- Daratumumab in the multiple myeloma treatment in the light of the last clinical trials2017 | Faculty of Medicine in Hradec Králové
- Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)2023 | Faculty of Medicine in Hradec Králové
- Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic2020 | Third Faculty of Medicine, Second Faculty of Medicine
- Repurposing anthelmintic agents to eradicate resistant leukemia2020 | Second Faculty of Medicine
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial2012 | First Faculty of Medicine
- Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine